DIAGNOSIS AND MANAGEMENT OF PRION DISEASE (CREUTZFELDT-JAKOB) SANTA CRUZ - BOLIVIA
Diagnóstico y manejo enfermedad de Priones
DOI:
https://doi.org/10.52428/20756208.v19i47.1205Keywords:
Creutzfeldt-Jakob disease, neuronal spongiform degeneration, Prion disease, neuronal damage, 14-3-3 proteinAbstract
Creutzfeldt-Jakob disease presents a progressive accumulation of extracellular amyloid plaques around neurons, causing neuronal spongiform degeneration and subsequently cell death. There are three forms of the disease: inherited, familial and sporadic, the latter characterized by progressive multifocal dementia with myoclonus.
A case of Creutzfeldt-Jakob disease is reported in the city of Santa Cruz de la Sierra - Bolivia. A 35-year-old patient with no history of the disease presented a 2-month clinical picture characterized by vertigo, myoclonus, dysarthria, decreased visual acuity, a condition that is exacerbated by generalized myoclonus, temporo-spatial disorientation and cognitive impairment. Initial differential diagnosis of drug-induced Parkinsonism, Meniere's syndrome and anxiety attacks, but finally the studies of detection of protein 14-3-3 in the CSF sample (Cerebrospinal fluid). They provided a value higher than the normal limit (limit: 1450 UA/mL; detected value 53100 UA/ml), analyzed together with the clinical data, he was diagnosed with Creutzfeldt-Jakob disease (Prion disease).
This case shows a male patient with an age younger than that of other studies that set an average age of 60 years or older. Like many other studies, cognitive impairment is an initial symptom and the progression of the disease and detection of the 14-3-3 protein is an indicative marker of neuronal damage, so multidisciplinary management and a strategic plan for resolution of complications were carried out, providing palliative care to improve his quality of life.
Keywords: Prion disease, Creutzfeldt-Jakob disease, neuronal damage, 14-3-3 protein, neuronal spongiform degeneration.
Downloads
References
Mohebbi A, Motamedaria P, Naderi M, et al. Understanding Creutzfeldt-Jakob disease in Iran: a systematic review of case reports. Int J Med Res. 2024;52(5) doi: Https://doi.org/10.1177/03000605241247.
https://doi.org/10.1177/03000605241247706
PMid:38717041 PMCid:PMC11080748
Cuadrado-Corrales, N. ; López-de-Andres, A. ; Hernández-Barrera, V. ; De-Miguel-Díez, J. ; Jiménez-Sierra, A. ; Carabantes-Alarcon, D. ; Zamorano-Leon, J.J. ; Jiménez-García, R. Enfermedad de Creutzfeldt-Jakob e insomnio familiar fatal: datos demográficos y mortalidad hospitalaria en España. J. Clin. Med. 2024, 13, 4401. https://doi.org/10.3390/jcm13154401.
https://doi.org/10.3390/jcm13154401
PMid:39124670 PMCid:PMC11312717
Rong LL, Lannen NJ, Tank EC, Feistel JL, Therasse CJ, Potluri A, Khan M and Min J (2023) Case report: Two clusters of Creutzfeldt-Jakob disease cases within 1 year in West Michigan. Front. Neurol. 14:1134225. https://doi.org/10.3389/fneur.2023.1134225.
https://doi.org/10.3389/fneur.2023.1134225
PMid:37021286 PMCid:PMC10067729
Zayas-Fundora E, Salgado-Fuentes C, Afonso-Domínguez M, Machado-Cueto M, Yllodo-Cristo A, Leyva-Pupo L. Caracterización de la enfermedad de Creutzfeldt-Jakob en el Instituto Nacional de Neurología y Neurocirugía en La Habana. Rev Cien Med Pinar Rio [Internet]. 2022 [citado 2024 Sep 1];26(5):[aprox. 0 p.]. Disponible en: https://revcmpinar.sld.cu/index.php/publicaciones/article/view/5619.
Mantilla Flórez YF, Muñoz Collazos MA, Pérez Díaz CE, Rodríguez Serrato L, Cañón Bustos S, Tuta EA. Enfermedad de Creutzfeldt-Jakob. Presentación de un caso y revisión de la literatura. Rev. Med. [Internet]. 1 de julio de 2020 [citado 17 de septiembre de 2024];27(2):103-11. Disponible en: https://revistas.unimilitar.edu.co/index.php/rmed/article/view/3759.
https://doi.org/10.18359/rmed.3759
Villagrán-Sancho D, Gómez-Fernández FJ, Luque-Ambrosiani AC, Hernández-Chamorro FJ, Franco-Macías E, Bernal-Sánchez Arjona M. Revisión de una serie de casos de enfermedad de Creutzfeldt-Jakob en un hospital de tercer nivel. Rev Neurol. 2023;77(12):299-304. https://doi.org/10.33588/rn.7712.2023257.
https://doi.org/10.33588/rn.7712.2023257
PMid:38095054 PMCid:PMC10831744
García-Ortega YE, Bravo-Ruiz OL, Mireles-Ramírez MA, Ramírez-Márquez JJ, Cabrera-Gaytán DA. Enfermedad de Creutzfeldt-Jakob. Med Int Méx. 2019 sep-oct;35(5):795-801. https://doi.org/10.24245/mim.v35i5.2583.
https://doi.org/10.24245/mim.v35i5.2583
Reyes HV, Muñoz NT, Hidalgo AL. Enfermedad de Creutzfeldt-Jakob: reporte de un caso. Scientifica [Internet]. 2014 [citado 2024 sep 25];12(1):125-8. Disponible en: http://revistasbolivianas.umsa.bo/scielo.php?script=sci_arttext&pid=S1813-00542014000100021&lng=es.
Rong LL, Lannen NJ, Tank EC, Feistel JL, Therasse CJ, Potluri A, Khan M, Min J. Informe de casos: dos grupos de casos de enfermedad de Creutzfeldt-Jakob en 1 año en el oeste de Michigan. Front Neurol. 2023;14:1134225. doi: 10.3389/fneur.2023.1134225.
https://doi.org/10.3389/fneur.2023.1134225
PMid:37021286 PMCid:PMC10067729
Orrú CD, Groveman BR, Hughson AG, Zanusso G, Coulthart MB, Caughey B. Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid. mBio. 2015 Jan 20;6(1):e02451-14. doi: 10.1128/mBio.02451-14. PMID: 25604790; PMCID: PMC4313917.
https://doi.org/10.1128/mBio.02451-14
PMid:25604790 PMCid:PMC4313917
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Dennis Marcelo Ticona Ledezma, María Elena Villca Mamani
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.